FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
EUROPEAN JOURNAL OF HAEMATOLOGY（2009）
摘要
The genotype of FCGR3A determines not only the response to rituximab, but also the levels of immunoglobulin after SCT and an adjuvant rituximab.
更多查看译文
关键词
rituximab,autologous peripheral blood stem cell transplantation,hypogammaglobulinemia,Fc gamma RIIIa,polymorphism
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要